Genentech, a member of the Roche Group; the American Cancer Society, Stand Up To Cancer, and Rally Health, launched a new cancer awareness initiative called "Cancer Screen Week."
The goal is to get Americans to pledge to get their recommended cancer screenings, which can detect cancers early, when they are most treatable.
This year, "Cancer Screen Week" took place December 4 - 8, and it will occur annually the first week of December.
Even though about half of all men and a third of all women will be diagnosed with cancer at some point in their lives, the overall cancer death rate has dropped by 25 percent over the past 20 years. Improvements in cancer screening and earlier detection of cancer have contributed to this progress.
"Screening can actually prevent some cancers by finding and treating abnormalities that turn into cancer if left alone," noted Rich Wender, MD, our chief cancer control officer. "'Cancer Screen Week' is a powerful reminder that it is possible to continue reducing cancer's deadly toll through recommended regular screenings."
"Cancer Screen Week" is an annual call to action for everyone to talk to their doctor and get their recommended cancer screenings, many of which may be covered by insurance.
Individuals were encouraged to visit www.GetScreenedNow.org to take the pledge to get screened and receive a personalized list of recommended screenings, plus a list of simple actions they can take to help lower their risk for certain types of cancers. People who take the pledge are urged to encourage their family and friends to take the pledge, as well.
Employers and providers can visit www.CancerScreenWeek.org to find turnkey, customizable campaign materials they can use to promote cancer screenings among their employee and patient populations.
"We want to encourage people to take the 'Get Screened Now' pledge to find out what screenings are recommended for them, and then to talk to their doctor about cancer screening," said Adam Bernstein, MD, Sc.D., chief medical officer, Rally Health. "These simple steps might just save their life."
To date, governors of Colorado, Florida, Georgia, Iowa, Kentucky, Maryland, Michigan, Minnesota, New York, Oregon, Pennsylvania, and Texas signed proclamations declaring the first week of December as "Cancer Screen Week" in their states, reinforcing the importance of cancer screening and early detection for their citizens.
For more information
More information is available at www.CancerScreenWeek.org, including downloadable and customizable resources, such as a fact sheet, poster, pledge card and appointment reminder card, for insurance providers, employers, healthcare providers, advocates, professional organizations, and people in the community who are interested in participating.
About our partner sponsors
Founded 40 years ago, Genentech is a leading biotechnology company that discovers, develops, manufactures, and commercializes medicines to treat patients with serious or life-threatening medical conditions. The company, a member of the Roche Group, has headquarters in South San Francisco.
Rally Health, Inc. is a consumer-centric digital health company that makes it easy for individuals to take charge of their health and collaborates with health plans, providers, and employers to engage consumers. The company's flagship offering is Rally®, a digital health platform that offers a suite of online and mobile solutions that help consumers manage their health and health care needs: Rally EngageSM focuses on personalized health and well-being support; Rally ChoiceSM is a health benefits marketplace; and Rally ConnectSM offers care provider search and cost transparency. More than 30 million consumers have access to the Rally platform.
Stand Up To Cancer
Stand Up To Cancer (SU2C) raises funds to accelerate the pace of research to get new therapies to patients quickly and save lives now. SU2C, a division of the Entertainment Industry Foundation (EIF), a 501(c)(3) charitable organization, was established in 2008 by film and media leaders who utilize the industry's resources to engage the public in supporting a new, collaborative model of cancer research, and to increase awareness about cancer prevention as well as progress being made in the fight against the disease.